Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P H Cottu

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Journal of Neuro-Oncology|September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepaA Comte, W Jdid, M N Guilhaume, et al.
British Journal of Cancer|November 27, 2001
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyP H Cottu, J M Extra, M Espie, et al.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
British Journal of Cancer|February 27, 2014
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimenS Giacchetti, R Porcher, J Lehmann-Che, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
Gynecologic Oncology|October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancerG E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years laterA Di Meglio, J Havas, M Pagliuca, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Journal of Neuro-Oncology|September 18, 2013
Survival of breast cancer patients with meningeal carcinomatosis treated by intrathecal thiotepaA Comte, W Jdid, M N Guilhaume, et al.
British Journal of Cancer|November 27, 2001
High-dose sequential epirubicin and cyclophosphamide with peripheral blood stem cell support for advanced breast cancer: results of a phase II studyP H Cottu, J M Extra, M Espie, et al.
Pathologie-Biologie|April 25, 2006
[Identification and management of hereditary breast-ovarian cancers (2004 update)]F Eisinger, B Bressac, D Castaigne, et al.
British Journal of Cancer|February 27, 2014
Long-term survival of advanced triple-negative breast cancers with a dose-intense cyclophosphamide/anthracycline neoadjuvant regimenS Giacchetti, R Porcher, J Lehmann-Che, et al.
ESMO Open|April 25, 2021
Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohortT Grinda, A Antoine, W Jacot, et al.
Gynecologic Oncology|October 13, 2021
Results of TRIO-14, a phase II, multicenter, randomized, placebo-controlled trial of carboplatin-paclitaxel versus carboplatin-paclitaxel-ganitumab in newly diagnosed epithelial ovarian cancerG E Konecny, A E Wahner Hendrickson, T M Davidson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 4, 2024
A bio-behavioral model of systemic inflammation at breast cancer diagnosis and fatigue of clinical importance 2 years laterA Di Meglio, J Havas, M Pagliuca, et al.
Pageof 4